Skip to main content

Table 2 Higher-valent pediatric combination vaccines and the timeline included in the NIPs in selected countries

From: Promoting higher-valent pediatric combination vaccines in China: challenges and recommendations for action

Category

U.S.

U.K.

Germany

Singapore

Malaysia

Brazil

Cambodia

China

Tetravalent vaccines

MMR (2006)

DTaP-IPV (2004)

MMR (2004)

–

–

MMR (2013)

–

–

DTaP-IPV (2008)

DTaP-IPV (2006)

Pentavalent vaccines

DTaP-HepB-IPV  (2003)

–

–

DTaP-IPV-Hib (2016)

–

DTwP-Hib-HepB  (2012)

DTwP-Hib-HepB  (2005)

–

DTaP-IPV-Hib  (2008)

Hexavalent vaccines

DTaP-IPV-Hib-HepB (2019)

DTaP-IPV-Hib-HepB (2017)

DTaP-IPV-Hib-HepB (2000)

–

DTaP-IPV-Hib-HepB  (2020)

–

–

–

  1. – means not applicable
  2. MMR Measles, mumps, and rubella; DTaP-IPV Diphtheria, tetanus, acellular pertussis, and polio; DTaP-HepB-IPV Diphtheria, tetanus, acellular pertussis, hepatitis B, and polio; DTaP-IPV-Hib Diphtheria, tetanus, acellular pertussis, polio, and Haemophilus influenzae type b; DTwP-Hib-HepB Diphtheria, tetanus, whole cell pertussis, Haemophilus influenzae type b, and hepatitis B; DTaP-IPV-Hib Diphtheria, tetanus, acellular pertussis, polio, and Haemophilus influenzae type b; DTaP-IPV-Hib-HepB Diphtheria, tetanus, acellular pertussis, polio, Haemophilus influenzae type b, and hepatitis B